Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

XTLbio signs license and asset purchase agreement with VivoQuest

Sep. 6, 2005

Therapeutic agents for gastrointestinal disorders claimed in patent literature

Sep. 5, 2005

Teduglutide benefits short bowel syndrome patients in phase II study

Sep. 2, 2005

Novel selective alpha4beta7/MAdCAM-1 antagonist reduces inflammation in mice with colitis

Sep. 1, 2005

New clinical data supports the use of methylnaltrexone in opioid-induced constipation

Sep. 1, 2005

Isatoribine induces antiviral effects in patients with chronic hepatitis C

Sep. 1, 2005

Bristol Myers seeks Japanese approval for Baraclude

Sep. 1, 2005

TAP Pharmaceutical to develop Takeda's TAK-390MR for acid disorders

Sep. 1, 2005

Novel therapeutics for hepatitis C virus infection reported

Aug. 30, 2005

Cotreatment with DA-9601 and omeprazole produces synergistic antiulcer effects in animal models

Aug. 24, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...